Incordex (ICDX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ICDX Annual Balance Sheets →
The data below summarizes Incordex's balance sheet position from Mar 31 2024 to Mar 31 2025, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & Short-term Investments0.00
Other Current Assets0.00
Total loans net0.00
Total Current Assets0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Mobile Application Net-
Website Net-
Total Assets0.00
Liabilities
Accounts Payable, Current AC0.00
Other Liabilities, Current0.00
Total Current Liabilities0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Due To Related Parties Noncurrent Amount-
Total Liabilities0.00
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock0.03
Retained Earnings / Accumulated Deficit-0.04
Other Equity0.00
Common Stockholder's Equity0.00
Total Stockholder's Equity0.00
Liabilities & Stockholder's Equity0.00
4 historic quarters locked

Sign in to unlock the full Incordex balance sheet history.

About Incordex Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250331)
  • Filed with the SEC: January 30, 2026
  • Source: icdx_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-26-000530

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.